首页> 外文期刊>ACS applied materials & interfaces >Synthesis and Preliminary in Vivo Evaluation of Well-Dispersed Biomimetic Nanocrystalline Apatites Labeled with Positron Emission Tomographic Imaging Agents
【24h】

Synthesis and Preliminary in Vivo Evaluation of Well-Dispersed Biomimetic Nanocrystalline Apatites Labeled with Positron Emission Tomographic Imaging Agents

机译:正电子发射断层显像剂标记的分散良好的仿生纳米晶磷灰石的合成及体内初步评价

获取原文
获取原文并翻译 | 示例
       

摘要

In recent years, biomimetic synthetic apatite nanoparticles (AP-NPs), having chemical similarity with the mineral phase of bone, have attracted a great interest in nanomedicine as potential drug carriers. To evaluate the therapeutic perspectives of AP-NPs through the mechanisms of action and organs they interact with, the noninvasive monitoring of their in vivo behavior is of paramount importance. To this aim, here the feasibility to radiolabel AP-NPs ("naked" and surface-modified with citrate to reduce their aggregation) with two positron emission tomographic (PET) imaging agents ([F-18]NaF and Ga-68-NO(2)AP(BP)) was investigated. [F-18]NaF was used for the direct incorporation of the radioisotope into the crystal lattice, while the labeling by surface functionalization was accomplished by using Ga-68-NO(2)AP(BP) (a new radio-metal chelating agent). The labeling results with both tracers were fast, straightforward, and reproducible. AP-NPs demonstrated excellent ability to bind relevant quantities of both radiotracers and good in vitro stability in clinically relevant media after the labeling. In vivo PET studies in healthy Wistar rats established that the radiolabeled AP-NPs gave significant PET signals and they were stable over the investigated time (90 min) since any tracer desorption was detected. These preliminary in vivo studies furthermore showed a clear ability of citrated versus naked AP-NPs to accumulate in different organs. Interestingly, contrary to naked AP-NPs, citrated ones, which unveiled higher colloidal stability in aqueous suspensions, were able to escape the first physiological filter, i.e., the lungs, being then accumulated in the liver and, to a lesser extent, in the spleen. The results of this work, along with the fact that AP-NPs can be also functionalized with targeting ligands, with therapeutic agents, and also with metals for a combination of different imaging modalities) make AP-NPs very encouraging materials for further investigations as theranostic agents in nanomedicine.
机译:近年来,与骨骼的矿物相具有化学相似性的仿生合成磷灰石纳米颗粒(AP-NP)在纳米医学中作为潜在的药物载体引起了极大的兴趣。为了通过作用机制和与之相互作用的器官评估AP-NP的治疗观点,非侵入性监测其体内行为至关重要。为此,在这里可以使用两种正电子发射断层扫描(PET)成像剂([F-18] NaF和Ga-68-NO)放射性标记AP-NP(“裸”的并用柠檬酸盐进行表面修饰以减少其聚集)研究了(2)AP(BP))。 [F-18] NaF用于将放射性同位素直接掺入晶格,而使用Ga-68-NO(2)AP(BP)(一种新型的放射性金属螯合剂)进行表面官能化标记)。两种示踪剂的标记结果均快速,简单且可重复。标记后,AP-NPs具有出色的结合两种放射性示踪剂的能力,并在临床相关介质中具有良好的体外稳定性。在健康的Wistar大鼠中进行的体内PET研究确定,放射性同位素标记的AP-NPs会发出明显的PET信号,并且在研究的时间内(90分钟)稳定,因为检测到任何示踪剂解吸。这些初步的体内研究进一步表明,柠檬酸的AP-NP与裸露的AP-NP在不同器官中积累的明显能力。有趣的是,与裸露的AP-NP相反,在水性悬浮液中具有较高胶体稳定性的柠檬酸型NPs能够逃脱第一个生理过滤器,即肺,然后聚集在肝脏中,并在较小程度上在肺中积累。脾。这项工作的结果,加上AP-NP也可以与靶向配体,治疗剂以及与金属结合使用以实现不同成像方式的组合这一事实,使AP-NP非常令人鼓舞,成为进一步治疗的材料纳米医学中的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号